CMS Increasing Audits

Submitted by admin on Tue, 01/03/2012 - 16:18

CMS has increased the audit cycle of MSA reporting as well as demands for conditional payments. The audits appear to be precautionary (not punitive), the demands of conditional payments typically follow the death of MSA beneficiary. Both inquiries are expertly handled by Medi-Bill and should be of no great concern to our clients. However, these two recent developments seem to indicate that CMS is becoming much more pragmatic regarding the accurate administration of MSA's and demonstrates the benefits of professionally administered MSAs over self administration.

New Website Launched

Submitted by admin on Tue, 09/28/2010 - 00:00

Medi-Bill is pleased to announce a complete website redesign. We hope you find our new design provides easier access to information and an intuitive layout for streamlined navigation.

CMS makes major benefit change to Part D Prescription Drugs

Submitted by admin on Thu, 05/20/2010 - 13:15

CMS (Centers for Medicaid/Medicare Services) has implemented a significant change to the Part D prescription drug benefit. As of 5/14/2010 prescription drugs that are being prescribed for "off-label" use will not be considered as a Part D reimbursable drug and the claim will be denied.

This means that even if the drug is listed on the Part D providers list of covered drugs, if it is being prescribed for a diagnosis that is "off-label" it will not be covered by Part D or the funds held in a Medicare Set Aside. However if the allocation proposal to CMS does include the future expense of Off Label application of specific prescriptions, then the Medicare Set Aside could pay the benefit.